{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T04:52:20Z","timestamp":1768279940347,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,31]]},"DOI":"10.7759\/cureus.65869","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T19:39:59Z","timestamp":1722454799000},"source":"Crossref","is-referenced-by-count":2,"title":["Classification and Management of Portal Vein Thrombosis in Cirrhotic Patients: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Abdulwahed A","family":"Alotay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.01.001","article-title":"Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis","volume":"40","author":"Amitrano L","year":"2004","unstructured":"Amitrano L, Guardascione MA, Brancaccio V, et al.. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol. 2004, 40:736-41. 10.1016\/j.jhep.2004.01.001","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2014.12.002","article-title":"Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis of observational studies","volume":"26","author":"Qi X","year":"2015","unstructured":"Qi X, De Stefano V, Li H, Dai J, Guo X, Fan D. Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis of observational studies. Eur J Intern Med. 2015, 26:23-9. 10.1016\/j.ejim.2014.12.002","journal-title":"Eur J Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-015-4012-2","article-title":"Direct oral anticoagulants in cirrhosis patients pose similar risks of bleeding when compared to traditional anticoagulation","volume":"61","author":"Intagliata NM","year":"2016","unstructured":"Intagliata NM, Henry ZH, Maitland H, Shah NL, Argo CK, Northup PG, Caldwell SH. Direct oral anticoagulants in cirrhosis patients pose similar risks of bleeding when compared to traditional anticoagulation. Dig Dis Sci. 2016, 61:1721-7. 10.1007\/s10620-015-4012-2","journal-title":"Dig Dis Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-018-1351-y","article-title":"Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function","volume":"130","author":"Scheiner B","year":"2018","unstructured":"Scheiner B, Stammet PR, Pokorny S, et al.. Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function. Wien Klin Wochenschr. 2018, 130:446-55. 10.1007\/s00508-018-1351-y","journal-title":"Wien Klin Wochenschr"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1053\/j.tvir.2016.01.005","article-title":"Thrombolysis and transjugular intrahepatic portosystemic shunt creation for acute and subacute portal vein thrombosis","volume":"19","author":"Chamarthy MR","year":"2016","unstructured":"Chamarthy MR, Anderson ME, Pillai AK, Kalva SP. Thrombolysis and transjugular intrahepatic portosystemic shunt creation for acute and subacute portal vein thrombosis. Tech Vasc Interv Radiol. 2016, 19:42-51. 10.1053\/j.tvir.2016.01.005","journal-title":"Tech Vasc Interv Radiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2017.05.020","article-title":"Transjugular local thrombolysis with\/without TIPS in patients with acute non-cirrhotic, non-malignant portal vein thrombosis","volume":"49","author":"Klinger C","year":"2017","unstructured":"Klinger C, Riecken B, Schmidt A, De Gottardi A, Meier B, Bosch J, Caca K. Transjugular local thrombolysis with\/without TIPS in patients with acute non-cirrhotic, non-malignant portal vein thrombosis. Dig Liver Dis. 2017, 49:1345-52. 10.1016\/j.dld.2017.05.020","journal-title":"Dig Liver Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-020-04624-4","article-title":"Systematic review of thrombolysis therapy in the management of non-cirrhosis-related portal vein thrombosis","volume":"25","author":"Cheng Q","year":"2021","unstructured":"Cheng Q, Tree K. Systematic review of thrombolysis therapy in the management of non-cirrhosis-related portal vein thrombosis. J Gastrointest Surg. 2021, 25:1579-90. 10.1007\/s11605-020-04624-4","journal-title":"J Gastrointest Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001194","article-title":"Anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis: a prospective observational study","volume":"116","author":"Lv Y","year":"2021","unstructured":"Lv Y, Bai W, Li K, et al.. Anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis: a prospective observational study. Am J Gastroenterol. 2021, 116:1447-64. 10.14309\/ajg.0000000000001194","journal-title":"Am J Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.21037\/cdt-21-98","article-title":"Narrative review of portal vein thrombosis in cirrhosis: pathophysiology, diagnosis, and management from an interventional radiology perspective","volume":"12","author":"Gadani S","year":"2022","unstructured":"Gadani S, Partovi S, Levitin A, et al.. Narrative review of portal vein thrombosis in cirrhosis: pathophysiology, diagnosis, and management from an interventional radiology perspective. Cardiovasc Diagn Ther. 2022, 12:135-46. 10.21037\/cdt-21-98","journal-title":"Cardiovasc Diagn Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.228023","article-title":"Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis","volume":"60","author":"Luca A","year":"2011","unstructured":"Luca A, Miraglia R, Caruso S, et al.. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Gut. 2011, 60:846-52. 10.1136\/gut.2010.228023","journal-title":"Gut"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2017.08.005","article-title":"Pretransplantation portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis: final analysis of a 61-patient cohort","volume":"28","author":"Thornburg B","year":"2017","unstructured":"Thornburg B, Desai K, Hickey R, et al.. Pretransplantation portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis: final analysis of a 61-patient cohort. J Vasc Interv Radiol. 2017, 28:1714-21.e2. 10.1016\/j.jvir.2017.08.005","journal-title":"J Vasc Interv Radiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4174\/astr.2019.96.5.230","article-title":"Analysis of risk factors for portal vein thrombosis after liver resection","volume":"96","author":"Han JH","year":"2019","unstructured":"Han JH, Kim DS, Yu YD, Jung SW, Yoon YI, Jo HS. Analysis of risk factors for portal vein thrombosis after liver resection. Ann Surg Treat Res. 2019, 96:230-6. 10.4174\/astr.2019.96.5.230","journal-title":"Ann Surg Treat Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200005150-00023","article-title":"Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome","volume":"69","author":"Yerdel MA","year":"2000","unstructured":"Yerdel MA, Gunson B, Mirza D, et al.. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation. 2000, 69:1873-81. 10.1097\/00007890-200005150-00023","journal-title":"Transplantation"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2010.12.002","article-title":"Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery","volume":"149","author":"Koch M","year":"2011","unstructured":"Koch M, Garden OJ, Padbury R, et al.. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery. 2011, 149:680-8. 10.1016\/j.surg.2010.12.002","journal-title":"Surgery"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8432781","article-title":"Newer oral anticoagulants in the treatment of acute portal vein thrombosis in patients with and without cirrhosis","volume":"2018","author":"Priyanka P","year":"2018","unstructured":"Priyanka P, Kupec JT, Krafft M, Shah NA, Reynolds GJ. Newer oral anticoagulants in the treatment of acute portal vein thrombosis in patients with and without cirrhosis. Int J Hepatol. 2018, 2018:8432781. 10.1155\/2018\/8432781","journal-title":"Int J Hepatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-019-3233-3","article-title":"A novel method detecting the key clinic factors of portal vein system thrombosis of splenectomy & cardia devascularization patients for cirrhosis & portal hypertension","volume":"20","author":"Wang M","year":"2019","unstructured":"Wang M, Ding L, Xu M, et al.. A novel method detecting the key clinic factors of portal vein system thrombosis of splenectomy & cardia devascularization patients for cirrhosis & portal hypertension. BMC Bioinformatics. 2019, 20:720. 10.1186\/s12859-019-3233-3","journal-title":"BMC Bioinformatics"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ags3.12383","article-title":"New classification-oriented treatment strategy for portal vein thrombosis after hepatectomy","volume":"4","author":"Onda S","year":"2020","unstructured":"Onda S, Furukawa K, Shirai Y, et al.. New classification-oriented treatment strategy for portal vein thrombosis after hepatectomy. Ann Gastroenterol Surg. 2020, 4:701-9. 10.1002\/ags3.12383","journal-title":"Ann Gastroenterol Surg"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.08.012","article-title":"Novel classification of non-malignant portal vein thrombosis: a guide to surgical decision-making during liver transplantation","volume":"71","author":"Bhangui P","year":"2019","unstructured":"Bhangui P, Lim C, Levesque E, Salloum C, Lahat E, Feray C, Azoulay D. Novel classification of non-malignant portal vein thrombosis: a guide to surgical decision-making during liver transplantation. J Hepatol. 2019, 71:1038-50. 10.1016\/j.jhep.2019.08.012","journal-title":"J Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13516","article-title":"Biliary reconstruction before clamp removal to avoid portal vein thrombosis in pediatric living-donor liver transplantation using hyper-reduced left lateral segment grafts: a novel technical strategy","volume":"23","author":"Glinka J","year":"2019","unstructured":"Glinka J, de Santiba\u00f1es M, Biagiola D, et al.. Biliary reconstruction before clamp removal to avoid portal vein thrombosis in pediatric living-donor liver transplantation using hyper-reduced left lateral segment grafts: a novel technical strategy. Pediatr Transplant. 2019, 23:e13516. 10.1111\/petr.13516","journal-title":"Pediatr Transplant"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/lt.25680","article-title":"A novel technique of physiological portal inflow augmentation during liver transplantation for Yerdel grade 4 portal vein thrombosis","volume":"26","author":"Puri Y","year":"2020","unstructured":"Puri Y, Gunasekaran V, Palanisamy SK, et al.. A novel technique of physiological portal inflow augmentation during liver transplantation for Yerdel grade 4 portal vein thrombosis. Liver Transpl. 2020, 26:294-8. 10.1002\/lt.25680","journal-title":"Liver Transpl"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn501113-20230310-00103","article-title":"Efficacy evaluation of novel oral anticoagulants in patients with cirrhosis accompanied with portal vein thrombosis: a meta-analysis","volume":"31","author":"Xu XT","year":"2023","unstructured":"Xu XT, Liu YW, Jin JL. Efficacy evaluation of novel oral anticoagulants in patients with cirrhosis accompanied with portal vein thrombosis: a meta-analysis. Zhonghua Gan Zang Bing Za Zhi. 2023, 31:614-20. 10.3760\/cma.j.cn501113-20230310-00103","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2018.00057","article-title":"Update on management of portal vein thrombosis and the role of novel anticoagulants","volume":"7","author":"Wu M","year":"2019","unstructured":"Wu M, Schuster M, Tadros M. Update on management of portal vein thrombosis and the role of novel anticoagulants. J Clin Transl Hepatol. 2019, 7:154-64. 10.14218\/JCTH.2018.00057","journal-title":"J Clin Transl Hepatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1715473","article-title":"New insights into the pathogenesis, risk factors, and treatment of portal vein thrombosis in patients with cirrhosis","volume":"46","author":"Nicoar\u0103-Farc\u0103u O","year":"2020","unstructured":"Nicoar\u0103-Farc\u0103u O, Soy G, Magaz M, et al.. New insights into the pathogenesis, risk factors, and treatment of portal vein thrombosis in patients with cirrhosis. Semin Thromb Hemost. 2020, 46:673-81. 10.1055\/s-0040-1715473","journal-title":"Semin Thromb Hemost"},{"key":"ref24","article-title":"Portal Vein Thrombosis","author":"Samant H","year":"2024","unstructured":"Samant H, Asafo-Agyei KO, Garfield K. Portal Vein Thrombosis. Samant H, Asafo-Agyei KO, Garfield K (ed): StatPearls, Treasure Island, FL; 2024."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.4103\/IJCIIS.IJCIIS_71_17","article-title":"Portal vein thrombosis: what surgeons need to know","volume":"8","author":"Quarrie R","year":"2018","unstructured":"Quarrie R, Stawicki SP. Portal vein thrombosis: what surgeons need to know. Int J Crit Illn Inj Sci. 2018, 8:73-7. 10.4103\/IJCIIS.IJCIIS_71_17","journal-title":"Int J Crit Illn Inj Sci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-7-34","article-title":"Portal vein thrombosis; risk factors, clinical presentation and treatment","volume":"7","author":"Sogaard KK","year":"2007","unstructured":"Sogaard KK, Astrup LB, Vilstrup H, Gronbaek H. Portal vein thrombosis; risk factors, clinical presentation and treatment. BMC Gastroenterol. 2007, 7:34. 10.1186\/1471-230X-7-34","journal-title":"BMC Gastroenterol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.04.042","article-title":"Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis: a systematic review and meta-analysis","volume":"153","author":"Loffredo L","year":"2017","unstructured":"Loffredo L, Pastori D, Farcomeni A, Violi F. Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis: a systematic review and meta-analysis. Gastroenterology. 2017, 153:480-7.e1. 10.1053\/j.gastro.2017.04.042","journal-title":"Gastroenterology"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2012.02785.x","article-title":"Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis","volume":"32","author":"Senzolo M","year":"2012","unstructured":"Senzolo M, M Sartori T, Rossetto V, et al.. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis. Liver Int. 2012, 32:919-27. 10.1111\/j.1478-3231.2012.02785.x","journal-title":"Liver Int"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.12112236","article-title":"Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis","volume":"265","author":"Luca A","year":"2012","unstructured":"Luca A, Caruso S, Milazzo M, et al.. Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis. Radiology. 2012, 265:124-32. 10.1148\/radiol.12112236","journal-title":"Radiology"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2015.02.012","article-title":"Association between portal vein thrombosis and risk of bleeding in liver cirrhosis: a systematic review of the literature","volume":"39","author":"Qi X","year":"2015","unstructured":"Qi X, Su C, Ren W, et al.. Association between portal vein thrombosis and risk of bleeding in liver cirrhosis: a systematic review of the literature. Clin Res Hepatol Gastroenterol. 2015, 39:683-91. 10.1016\/j.clinre.2015.02.012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50385","article-title":"Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators","volume":"38","author":"D'Amico G","year":"2003","unstructured":"D'Amico G, De Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology. 2003, 38:599-612. 10.1053\/jhep.2003.50385","journal-title":"Hepatology"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2013.08.138","article-title":"Impact of portal vein thrombosis on the efficacy of endoscopic variceal band ligation","volume":"46","author":"Dell'Era A","year":"2014","unstructured":"Dell'Era A, Iannuzzi F, Fabris FM, et al.. Impact of portal vein thrombosis on the efficacy of endoscopic variceal band ligation. Dig Liver Dis. 2014, 46:152-6. 10.1016\/j.dld.2013.08.138","journal-title":"Dig Liver Dis"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.10.016","article-title":"Harmful and beneficial effects of anticoagulants in patients with cirrhosis and portal vein thrombosis","volume":"16","author":"La Mura V","year":"2018","unstructured":"La Mura V, Braham S, Tosetti G, et al.. Harmful and beneficial effects of anticoagulants in patients with cirrhosis and portal vein thrombosis. Clin Gastroenterol Hepatol. 2018, 16:1146-52.e4. 10.1016\/j.cgh.2017.10.016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0421-0","article-title":"Clinical impact and safety of anticoagulants for portal vein thrombosis in cirrhosis","volume":"114","author":"Pettinari I","year":"2019","unstructured":"Pettinari I, Vukotic R, Stefanescu H, et al.. Clinical impact and safety of anticoagulants for portal vein thrombosis in cirrhosis. Am J Gastroenterol. 2019, 114:258-66. 10.1038\/s41395-018-0421-0","journal-title":"Am J Gastroenterol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.12.003","article-title":"Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats","volume":"64","author":"Cerini F","year":"2016","unstructured":"Cerini F, Vilaseca M, Lafoz E, et al.. Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats. J Hepatol. 2016, 64:834-42. 10.1016\/j.jhep.2015.12.003","journal-title":"J Hepatol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29084","article-title":"The anticoagulant rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells","volume":"65","author":"Vilaseca M","year":"2017","unstructured":"Vilaseca M, Garc\u00eda-Calder\u00f3 H, Lafoz E, et al.. The anticoagulant rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells. Hepatology. 2017, 65:2031-44. 10.1002\/hep.29084","journal-title":"Hepatology"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.07.018","article-title":"Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis","volume":"143","author":"Villa E","year":"2012","unstructured":"Villa E, Camm\u00e0 C, Marietta M, et al.. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. Gastroenterology. 2012, 143:1253-60.e4. 10.1053\/j.gastro.2012.07.018","journal-title":"Gastroenterology"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e3181b3ab44","article-title":"Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis","volume":"44","author":"Amitrano L","year":"2010","unstructured":"Amitrano L, Guardascione MA, Menchise A, et al.. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol. 2010, 44:448-51. 10.1097\/MCG.0b013e3181b3ab44","journal-title":"J Clin Gastroenterol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastrohep.2018.06.005","article-title":"Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis","volume":"41","author":"Artaza T","year":"2018","unstructured":"Artaza T, Lopes M, Romero M, et al.. Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis. Gastroenterol Hepatol. 2018, 41:611-7. 10.1016\/j.gastrohep.2018.06.005","journal-title":"Gastroenterol Hepatol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.01.012","article-title":"Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis","volume":"10","author":"Delgado MG","year":"2012","unstructured":"Delgado MG, Seijo S, Yepes I, et al.. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. Clin Gastroenterol Hepatol. 2012, 10:776-83. 10.1016\/j.cgh.2012.01.012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2018.11.011","article-title":"Portal vein thrombosis and liver cirrhosis: long-term anticoagulation is effective and safe","volume":"43","author":"Berg\u00e8re M","year":"2019","unstructured":"Berg\u00e8re M, Erard-Poinsot D, Boillot O, Valette PJ, Guillaud O, Chambon-Augoyard C, Dumortier J. Portal vein thrombosis and liver cirrhosis: long-term anticoagulation is effective and safe. Clin Res Hepatol Gastroenterol. 2019, 43:395-402. 10.1016\/j.clinre.2018.11.011","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-012-2548-y","article-title":"Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation","volume":"58","author":"Werner KT","year":"2013","unstructured":"Werner KT, Sando S, Carey EJ, et al.. Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation. Dig Dis Sci. 2013, 58:1776-80. 10.1007\/s10620-012-2548-y","journal-title":"Dig Dis Sci"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2018.05.002","article-title":"Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis","volume":"113","author":"Hanafy AS","year":"2019","unstructured":"Hanafy AS, Abd-Elsalam S, Dawoud MM. Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis. Vascul Pharmacol. 2019, 113:86-91. 10.1016\/j.vph.2018.05.002","journal-title":"Vascul Pharmacol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2014.20.4.384","article-title":"Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis","volume":"20","author":"Chung JW","year":"2014","unstructured":"Chung JW, Kim GH, Lee JH, Ok KS, Jang ES, Jeong SH, Kim JW. Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis. Clin Mol Hepatol. 2014, 20:384-91. 10.3350\/cmh.2014.20.4.384","journal-title":"Clin Mol Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/272285-classification-and-management-of-portal-vein-thrombosis-in-cirrhotic-patients-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T19:40:05Z","timestamp":1722454805000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/272285-classification-and-management-of-portal-vein-thrombosis-in-cirrhotic-patients-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,31]]},"references-count":44,"URL":"https:\/\/doi.org\/10.7759\/cureus.65869","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,31]]}}}